Several strategies are currently being pursued in an attempt to extend the circulating half life of both novel and existing proteins. Premier biopharmaceutical companies will discuss the methods that are being used to extend specific therapeutic proteins as well as detailing the beneficial effects of such half life extension.

• Learn about novel technologies currently under investigation for half life extension of proteins
• Discuss key terms and conditions that are important to consider from a business development perspective in finalizing these deals
• How will this segment of the biotherapeutics market evolve over the next 10 years